Computer-based de novo designs of tripeptides as novel neuraminidase inhibitors

International Journal of Molecular Sciences

Volumn 11, Issue 12, 2010, Pages 4932-4951

  Yang, Zhiwei ^a   Yang, Gang ^a,b   Zu, Yuangang ^a   Fu, Yujie ^a   Zhou, Lijun ^a  

^a NORTHEAST FORESTRY UNIVERSITY   (China)

^b DALIAN INSTITUTE OF CHEMICAL PHYSICS   (China)

Author keywords

De novo drug designs; Docking; H bonds; Influenza; Neuraminidase inhibitors; Tripeptides

Indexed keywords

ASPARTIC ACID; GLUTAMIC ACID; PHENYLALANINE; PHENYLALANYLARGINYLGLYCINE; PHENYLALANYLARGINYLISOLEUCINE; PHENYLALANYLARGINYLSERINE; PHENYLALANYLARGINYLTHREONINE; PHENYLALANYLARGINYLVALINE; PHENYLALANYLHISTIDYLVALINE; SIALIDASE INHIBITOR; TRIPEPTIDE DERIVATIVE; TYROSYLARGINYLVALINE; UNCLASSIFIED DRUG; VIRUS SIALIDASE; ENZYME INHIBITOR; NA PROTEIN, INFLUENZA A VIRUS; OLIGOPEPTIDE; SIALIDASE; VIRUS PROTEIN;

AMINO TERMINAL SEQUENCE; ARTICLE; BINDING AFFINITY; CARBOXY TERMINAL SEQUENCE; COMPUTER AIDED DESIGN; CONTROLLED STUDY; DRUG DESIGN; DRUG PROTEIN BINDING; DRUG SPECIFICITY; DRUG STRUCTURE; ENZYME ACTIVE SITE; HYDROPHOBICITY; MOLECULAR DOCKING; MOLECULAR DYNAMICS; ANTAGONISTS AND INHIBITORS; CHEMISTRY; COMPUTER SIMULATION; ENZYMOLOGY; INFLUENZA VIRUS A H1N1; SYNTHESIS;

COMPUTER SIMULATION; DRUG DESIGN; ENZYME INHIBITORS; INFLUENZA A VIRUS, H1N1 SUBTYPE; NEURAMINIDASE; OLIGOPEPTIDES; VIRAL PROTEINS;

EID: 78650986019     PISSN: None     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms11124932     Document Type: Article

References (60)

1. Colman, P.M.; Varghese, J.N.; Laver, W.G. Structure of the catalytic and antigenic sites in influenza virus neuraminidase. Nature 1983, 303, 41-44.
2. von Itzstein, M. The war against influenza: discovery and development of sialidase inhibitors. Nat. Rev. Drug. Discov. 2007, 6, 967-974.
3. Itoh, Y.; Shinya, K.; Kiso, M.; Watanabe, T.; Sakoda, Y.; Hatta, M.; Muramoto, Y.; Tamura, D.; Sakai-Tagawa, Y.; Noda, T. et al. In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses. Nature 2009, 460, 1021-1025.
4. Moscona, A. Medical management of influenza infection. Annu. Rev. Med. 2008, 59, 397-413.
5. Moscona, A. Neuraminidase inhibitors for influenza. N. Engl. J. Med. 2005, 353, 1363-1373.
6. Ward, P.; Small, I.; Smith, J.; Suter, P.; Dutkowski, R. Oseltamivir (Tamiflu) and its potential for use in the event of an influenza pandemic. J. Antimicrob. Chemother. 2005, 55(Suppl. S1), i5-i21.
7. Beigel, J.; Bray, M. Current and future antiviral therapy of severe seasonal and avian influenza. Antivir. Res. 2008, 78, 91-102.
8. Gubareva, L.V. Molecular mechanisms of influenza virus resistance to neuraminidase inhibitors. Virus Res. 2004, 103, 199-203.
9. de Jong, M.D.; Tran, T.T.; Truong, H.K.; Vo, M.H.; Smith, G.J.; Nguyen, V.C.; Bach, V.C.; Phan, T.Q.; Do, Q.H.; Guan, Y.; Peiris, J.S.; Tran, T.H.; Farrar, J. Oseltamivir resistance during treatment of influenza A (H5N1) infection. N. Engl. J. Med. 2005, 353, 2667-2672.
10. Bautista, E.; Chotpitayasunondh, T.; Gao, Z.; Harper, S.A.; Shaw, M.; Uyeki, T.M.; Zaki, S.R.; Hayden, F.G.; Hui, D.S.; Kettner, J.D.; Kumar, A.; Lim, M.; Shindo, N.; Penn, C.; Nicholson, K.G. Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection. N. Engl. J. Med. 2010, 362, 1708-1719.
11. de Clercq, E.; Neyts, J. Avian influenza A (H5N1) infection: targets and strategies for chemotherapeutic intervention. Trends Pharmacol. Sci. 2007, 28, 280-285.
12. Garman, E.; Laver, G. Controlling influenza by inhibiting the virus's neuraminidase. Curr. Drug Targets 2004, 5, 119-136.
13. Russell, R.J.; Haire, L.F.; Stevens, D.J.; Collins, P.J.; Lin, Y.P.; Blackburn, G.M.; Hay, A.J.; Gamblin, S.J.; Skehel, J.J. The structure of H5N1 avian influenza neuraminidase suggests new opportunities for drug design. Nature 2006, 443, 45-49.
14. Aruksakunwong, O.; Malaisree, M.; Decha, P.; Sompornpisut, P.; Parasuk, V.; Pianwanit, S.; Hannongbua, S. On the lower susceptibility of oseltamivir to influenza neuraminidase subtype N1 than those in N2 and N9. Biophys. J. 2007, 92, 798-807.
15. Das, K.; Aramini, J.M.; Ma, L.C.; Krug, R.M.; Arnold, E. Structures of influenza A proteins and insights into antiviral drug targets. Nat. Struct. Mol. Biol. 2010, 17, 530-538.
16. Varghese, J.N.; Epa, V.C.; Colman, P.M. Three-dimensional structure of the complex of 4-guanidino-Neu5Ac2en and influenza virus neuraminidase. Protein Sci. 1995, 4, 1081-1087.
17. Varghese, J.N.; Smith, P.W.; Sollis, S.L.; Blick, T.J.; Sahasrabudhe, A.; McKimm-Breschkin, J.L.; Colman, P.M. Drug design against a shifting target: A structural basis for resistance to inhibitors in a variant of influenza virus neuraminidase. Structure 1998, 6, 735-746.
18. Smith, B.J.; Colman, P.M.; von Itzstein, M.; Danylec, B.; Varghese, J.N. Analysis of inhibitor binding in influenza virus neuraminidase. Protein Sci. 2001, 10, 689-696.
19. Smith, B.J.; McKimm-Breshkin, J.L.; McDonald, M.; Fernley, R.T.; Varghese, J.N.; Colman, P.M. Structural Studies of the Resistance of Influenza Virus Neuramindase to Inhibitors. J. Med. Chem. 2002, 45, 2207-2212.
20. von Itzstein, M.; Wu, W.Y.; Kok, G.B.; Pegg, M.S.; Dyason, J.C.; Jin, B.; van Phan, T.; Smythe, M.L.; White, H.F.; Oliver, S.W. Rational design of potent sialidase-based inhibitors of influenza virus replication. Nature 1993, 363, 418-423.
21. Kim, C.U.; Lew, W.; Williams, M.A.; Liu, H.; Zhang, L.; Swaminathan, S.; Bischofberger, N.; Chen, M.S.; Mendel, D.B.; Tai, C.Y. Influenza neuraminidase inhibitors possessing a novel hydrophobic interaction in the enzyme active site: design, synthesis, and structural analysis of carbocyclic sialic acid analogues with potent anti-influenza activity. J. Am. Chem. Soc. 1997, 119, 681-690.
22. Jones, J.C.; Turpin, E.A.; Bultmann, H.; Brandt, C.R.; Schultz-Cherry, S. Inhibition of influenza virus infection by a novel antiviral peptide that targets viral attachment to cells. J. Virol. 2006, 80, 11960-11967.
23. Kuang, Z.Z.; Zheng, L.S.; Li, S.; Duan, Z.J.; Qi, Z.Y.; Qu, X.W.; Liu, W.P.; Zhang, W.J.; Li, D.D.; Gao, H.C.; Hou, Y.D. Screening of peptides as broad-spectrum neuraminidase inhibitors against influenza viruses. Chin. J. Virol. 2007, 23, 165-171.
24. Matsubara, T.; Sumi, M.; Kubota, H.; Taki, T.; Okahata, Y.; Sato, T. Inhibition of influenza virus infections by sialylgalactose-binding peptides selected from a phage library. J. Med. Chem. 2009, 52, 4247-4256.
25. Rajik, M.; Jahanshiri, F.; Omar, A.R.; Ideris, A.; Hassan, S.S.; Yusoff, K. Identification and characterisation of a novel anti-viral peptide against avian influenza virus H9N2. Virol. J. 2009, 6, 74.
26. Bray, B.L. Large-scale manufacture of peptide therapeutics by chemical synthesis. Nat. Rev. Drug Discov. 2003, 2, 587-593.
27. Owens, J. Building blocks for peptide drugs. Nat. Rev. Drug Discov. 2004, 3, 476-476.
28. Rappocciolo, E. Antimicrobial peptides as carriers of drugs. Drug Discov. Today 2004, 9, 470.
29. Watt, P.M. Screening for peptide drugs from the natural repertoire of biodiverse protein folds. Nat. Biotechnol. 2006, 24, 177-183.
30. Haine, E.R.; Moret, Y.; Siva-Jothy, M.T.; Rolff, J. Antimicrobial defense and persistent infection in insects. Science 2008, 322, 1257-1259.
31. Bender, F.C.; Whitbeck, J.C.; Lou, H.; Cohen, G.H.; Eisenberg, R.J. Herpes simplex virus glycoprotein B binds to cell surfaces independently of heparan sulfate and blocks virus entry. J. Virol. 2005, 79, 11588-11597.
32. Townsend, D.M.; Tew, K.D.; Tapiero, H. The importance of glutathione in human disease. Biomed. Pharmacother. 2003, 57, 145-155.
33. Shen, G.X. Development and current applications of thrombin-specific inhibitors. Curr. Drug Targets Cardiovasc. Haematol. Disord. 2001, 1, 41-49.
34. Kiso, Y. Design and synthesis of substrate-based peptidomimetic human immunodeficiency virus protease inhibitors containing the hydroxymethylcarbonyl isostere. Biopolymers 1996, 40, 235-244.
35. Njoroge, F.G.; Chen, K.X.; Shih, N.Y.; Piwinski, J.J. Challenges in modern drug discovery: a case study of boceprevir, an HCV protease inhibitor for the treatment of hepatitis C virus infection. Acc. Chem. Res. 2008, 41, 50-59.
36. Luger, T.A.; Scholzen, T.E.; Brzoska, T.; Bohm, M. New insights into the functions of alpha-MSH and related peptides in the immune system. Ann. N.Y. Acad. Sci. 2003, 994, 133-140.
37. Yang, Z.W.; Yang, G.; Zu, Y.G.; Fu, Y.J.; Zhou, L.J. The conformational analysis and proton transfer of the neuraminidase inhibitors: a theoretical study. Phys. Chem. Chem. Phys. 2009, 11, 10035-10041.
38. Yang, Z.; Nie, Y.; Yang, G.; Zu, Y.; Fu, Y.; Zhou, L. Synergistic effects in the designs of neuraminidase ligands: Analysis from docking and molecular dynamics studies. J. Theor. Biol. 2010, 267, 363-374.
39. Masukawa, K.M.; Kollman, P.A.; Kuntz, I.D. Investigation of Neuraminidase-Substrate Recognition Using Molecular Dynamics and Free Energy Calculations. J. Med. Chem. 2003, 46, 5628-5637.
40. Bonnet P., Bryce R.A. Molecular dynamics and free energy analysis of neuraminidase-ligand interactions. Protein Sci. 2004, 13, 946-957.
41. Bonnet, P.; Bryce, R.A. Scoring binding affinity of multiple ligands using implicit solvent and a single molecular dynamics trajectory: Application to Influenza neuraminidase. J. Mol. Graph. Model. 2005, 24, 147-156.
42. Stoll, V.; Stewart, K.D.; Maring, C.J.; Muchmore, S.; Giranda, V.; Gu, Y.-G.Y.; Wang, G.; Chen, Y.; Sun, M.; Zhao, C.; Kennedy, A.L.; Madigan, D.L.; Xu, Y.; Saldivar, A.; Kati, W.; Laver, G.; Sowin, T.; Sham, H.L.; Greer, J.; Kempf, D. Influenza neuraminidase inhibitors: structure-based design of a novel inhibitor series. Biochemistry 2003, 42, 718-727.
43. Yang, G.; Yang, Z.W.; Zu, Y.G.; Wu, X.M.; Fu, Y.J. The calcium ion and conserved water molecules in neuraminidases: roles and implications for substrate binding. Internet. Electron. J. Mol. Des. 2008, 7, 97-113.
44. Amaro, R.E.; Cheng, X.; Ivanov, I.; Xu, D.; McCammon, J.A. Characterizing Loop Dynamics and Ligand Recognition in Human- and Avian-Type Influenza Neuraminidases via Generalized Born Molecular Dynamics and End-Point Free Energy Calculations. J. Am. Chem. Soc. 2009, 131, 4702-4709.
45. Colman, P.M. Influenza virus neuraminidase: structure, antibodies, and inhibitors. Protein Sci. 1994, 3, 1687-1696.
46. Yang, Z.W.; Zu, Y.G.; Wu, X.M.; Liu, C.B.; Yang, G. A computational investigation on the interaction mechanisms of neuraminidases and 3-(3-pentyloxy)benzoic acid. Acta. Chimica. Sinica. 2010, 14, 1370-1378.
47. InisghtII, 2005; Accelrys Inc.: San Diego, CA, USA; 2005.
48. Wall, I.D.; Leach, A.R.; Salt, D.W.; Ford, M.G.; Essex, J.W. Binding constants of neuraminidase inhibitors: An investigation of the linear interaction energy method. J. Med. Chem. 1999, 42, 5142-5152.
49. Frisch, M.J.; Trucks, G.W.; Schlegel, H.B.; Scuseria, G.E.; Robb, M.A.; Cheeseman, J.R.; Montgomery, J.A.; Vreven, T., Jr.; Kudin, K.N.; Burant, J.C. et al. Gaussian 03, Revision D.01; Gaussian, Inc.: Wallingford, CT, USA, 2004.
50. Yang, Z.W.; Wu, X.M.; Zhou, L.J.; Yang, G. A proline-based neuraminidase inhibitor: DFT studies on the zwitterion conformation, stability and formation. Int. J. Mol. Sci. 2009, 10, 3918-3930.
51. Affinity User Guide; Accelrys Inc.: San Diego, CA, USA; 2005.
52. Jorgensen, W.L.; Chandrasekhar, J.; Madura, J.D.; Impey, R.W.; Klein, M.L. Comparison of simple potential functions for simulating liquid water. J. Chem. Phys. 1983, 79, 926-935.
53. Adelman, S.A.; Doll, J.D. Generalized Langevin equation approach for atom/solid-surface scattering: General formulation for classical scattering off harmonic solids. J. Chem. Phys. 1976, 64, 2375-2388.
54. Shamovsky, I.L.; Ross, G.M.; Riopelle, R.J. Theoretical studies on the origin of β-sheet twisting. J. Phys. Chem. B 2000, 104, 11296-11307.
55. Bouř, P.; Buděšínský, M.; Špirko, V.; Kapitán, J.; Šebestík, J.; Sychrovský, V. A complete set of NMR chemical shifts and spin-spin coupling constants for l-alanyl-l-alanine zwitterion and analysis of its conformational behavior. J. Am. Chem. Soc. 2005, 127, 17079-17089.
56. Kang, Y.K.; Scheraga, H.A. An efficient method for calculating atomic charges of peptides and proteins from electronic populations. J. Phys. Chem. B 2008, 112, 5470-5478.
57. LaPointe, S.M.; Farrag, S.; Bohórque, H.J.; Boyd, R.J. QTAIM study of an α-helix hydrogen bond network. J. Phys. Chem. B 2009, 113, 10957-10964.
58. Yang, G.; Zu, Y.; Fu, Y.; Zhou, L.; Zhu, R.; Liu, C. Assembly and stabilization of multi-amino acid zwitterions by the Zn(II) ion: a computational exploration. J. Phys. Chem. B 2009, 113, 4899-4906.
59. Yang, G.; Xing, C.; Liu, C.-B.; Fu, Y.-J.; Zhou, L.-J.; Zu, Y.-G. First-principle conformational analysis of glycine residues in the αβ-tubulin dimer. Interdiscip. Sci.: Comput. Life Sci. 2009, 1, 196-203.
60. Yang, G.; Zu, Y.; Liu, C.; Fu, Y.; Zhou, L. Stabilization of amino acid zwitterions with varieties of anionic species: the intrinsic mechanism. J. Phys. Chem. B 2008, 112, 7104-7110.